"As of today, Russia's FMBA has created three prototypes of the vaccine. These are recombinant proteins based on epitopes of the surface S-protein SARS-CoV-2. We have launched immunological potency tests on mice," the FMBA said in a statement.
The results of pilot tests are expected in June, and the second stage of the research is expected to be completed by the beginning of the third quarter of the year.
FMBA head, ex-Russian Health Minister Veronika Skvortsova added that the vaccine would be ready in 11 months.